Skip to main content

CellSource Co., Ltd. (4880.T)

Japan Exchange Group Healthcare BiotechnologyView data quality →
45.7Fair

ValueMarkers Composite Index

Top 18%#36,873 of 44,707
Undervalued

76% below intrinsic value ($11)

UndervaluedFair ValueOvervalued
Piotroski
5/9
Neutral
Beneish
-2.75
Low Risk
Altman
6.39
Safe
DCF Value
$11
Undervalued
ROIC
1.8%
Low
P/E
87.0
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

CellSource Co., Ltd. (4880.T) — VMCI valuation read

4880.T prints VMCI 46/100 inside the Healthcare sector, where the median sits at 50. The 4-point below-median delta is the cleanest single-number summary of CellSource Co., Ltd.'s composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On 4880.T, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** 4880.T trades at 18.0x earnings, 0% above the Healthcare median of 18.0x; that is the value line. ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 1.2x leaves covenant headroom; that is the risk line for CellSource Co., Ltd. on the trailing financials.

4880.T rose 2.4% over the trailing 7 days, with a -23.5% read on a 30-day basis.

CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

CEO: Masayuki Yamakawa151 employeesJPwww.cellsource.co.jp

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 4880.T’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.